Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis

Journal of Rheumatology

Volumn 23, Issue 7, 1996, Pages 1135-1142

  Cherin, Patrick ^a,b   Herson, Serge ^a   Crevon, Marie Claude ^b   Hauw, Jean Jacques ^a   Cervera, Pascale ^a   Galanaud, Pierre ^a   Emilie, Dominique ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

CYTOTOXIC CELLS; DERMATOMYOSITIS; GRANZYME B; PERFORIN; POLYMYOSITIS; TIA 1 PROTEIN

Indexed keywords

ASPARAGINASE; COMPLEMENTARY DNA; CORTICOSTEROID; CYCLOSPORIN A; DNA FRAGMENT; MONOCLONAL ANTIBODY; PERFORIN; PREDNISONE; PROTEINASE; RNA BINDING PROTEIN; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DERMATOMYOSITIS; FEMALE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MALE; MUSCLE BIOPSY; MYOSITIS; PATHOGENESIS; PHENOTYPE; POLYMYOSITIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, CD3; ANTISENSE ELEMENTS (GENETICS); BIOLOGICAL MARKERS; BIOPSY; CELL LINEAGE; DERMATOMYOSITIS; FEMALE; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANZYMES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE, SKELETAL; PHENOTYPE; POLY(A)-BINDING PROTEINS; POLYMYOSITIS; PORE FORMING CYTOTOXIC PROTEINS; PROTEINS; RNA-BINDING PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029945488     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies. Ann Neurol 1984;16:193-208.
2. Kalovidouris AE: The role of cell-mediated immunity in polymyositis. Curr Opin Rheumatol 1991;3:911-8.
3. McCarty GA: Autoantibodies in scleroderma and polymyositis: An update. Semin Dermatol 1991;10:206-16.
4. Cherin P, Herson S, Godeau P: Physiopathogénie des dermatomyosites et polymyosites. Ann Méd Interne (Paris) 1990;141:156-9.
5. Giorno R, Ringel SP: Analysis of macrophages, activated cells and T cell subsets in inflammatory myopathies using monoclonal antibodies. Pathol Immunopathol Res 1986;5:491-9.
6. Lancki DW, Hsieh CS, Fitch FW: Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. J Immunol 1991;146:3242-9.
7. Griffith GM, Mueller C: Expression of perforin and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991;12:415-9.
8. Podack ER, Hengartner H, Lichterheld MG: A central role of perform in cytolysis? Annu Rev Immunol 1991;9:129-57.
9. Krähenbühl O, Tschopp J: Perforin-induced pore formation. Immunol Today 1991;12:399-419.
10. Tschopp J, Schafer S, Masson D, Peitch MC, Heusser C: Phosphorylcholine acts as a Ca-dependent receptor molecule for lymphocyte perforin. Nature 1989;337:272-4.
11. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P: A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991;67:629-39.
12. Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Young JDE: Perforin and serine esterase gene expression in stimulated human T cells. J Exp Med 1989;170:2105-18.
13. Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7;403-7.
14. Trapani JA, Klein JL, White PC, Dupont B: Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes. Proc Natl Acad Sci USA 1988;85:6924.
15. Peuchmaur M, Emilie D, Crevon MC, et al: IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol 1990;136:383-90.
16. Emilie D, Peuchmaur M, Maillot MC, et al: Production of interleukins in human immunodeficiency virus-1 replicating lymph nodes. J Clin Invest 1990;86:148-59.
17. Anderson P, Nagler-Anderson C, O'Brien C, et al: A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990;144:574-82.
18. Mason DY, Sammons RE: The labeled antigen method of immunoenzymatic staining. J Histochem Cytochem 1979;27:832-40.
19. Lemoine NR, Ryan JF, Cox EL, Mayston V, Revell PA, Swash M: Immunohistochemical analysis of mononuclear cell subsets in inflammatory and non-inflammatory myopathies. J Clin Pathol 1986;39:271-4.
20. Engel AG, Arahata K: Mononuclear cells in myopathies. Hum Pathol 1986;17:704-72.
21. Strongwater SL, Dorovini K, Ball RD, Schnitzer TJ: A murine model of polymyositis induced by Coxsackievirus B 1 (Tucson strain). Arthritis Rheum 1984;21:431-42.
22. Bowles NE, Dubowitz V, Sewry CA, Archard LC: Dermatomyositis, polymyositis and Coxsackie-B-virus infection. Lancet 1987;1:1004-7.
23. Dalakas MC, Pezeshkpour GH, Gravell M, Sever JL: Polymyositis associated with AIDS retrovirus. JAMA 1986;256:2381-3.
24. Ishii K, Yamato K, Iwahara Y, et al: Isolation of HTLV-1 from muscle of a patient with polymyositis. Am J Med 1991;90:267-9.
25. Leff RL, Love LA, Miller FW, et al: Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle. Lancet 1992;1:1192-5.
26. Cucher BG, Goldman AL: D-penicillamine-induced polymyositis in rheumatoid arthritis. Ann Intern Med 1976;85:615-6.
27. Hawkins RA, Eckhoff Jr PJ, MacCarter DK, Harmon CE: Cimetidine and polymyositis. N Engl J Med 1983;309:187-8.
28. Behan WMH, Behan PO, Micklem HS, Durward WF: Abnormalities of lymphocyte subsets in polymyositis. BMJ 1983;287:181-2.
29. Behan WMH, Behan PO: Disturbance of regulatory lymphocyte subsets in polymyositis. Ann Neurol 1984;15:112-4.
30. Miller FW, Love LA, Barbieri A, Balow JE, Plotz PH: Lymphocyte activation markers in idiopathic myositis: Changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 1990;8:373-9.
31. Gonzalez-Amaro R, Alcocer-Varela J, Alarcon-Segovia D: Natural killer cell activity in dermatomyositis-polymyositis. J Rheumatol 1987;14:301-10.
32. Wolf RE, Baethge BA: Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum 1990;33:1007-14.
33. Currie S, Saunders M, Knowles M, Brown AE: Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med 1971;40:63-84.
34. Johnson RL, Fink CW, Ziff M: Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest 1972;51:2435-49.
35. McDouall RM, Dunn MJ, Dubowitz V: Nature of (he mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 1990;99:199-217.
36. Crowe WE, Bove KE, Levinbon JE, Hilton PK: Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 1982;25:126-39.
37. Kissel JT, Mendell JR, Rammohan KW: Microvascular deposition of complement attack complex in dermatomyositis. N Engl J Med 1986;314:329-34.
38. Whitaker JN, Engel WK: Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med 1972;286:333-8.
39. Jerusalem F, Rakusa M, Engel AG, McDonald RD: Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies. J Neurol Sci 1974;23:301-2.
40. Banker BQ, Victor M: Dermatomyositis (systemic angiopathy) of childhood. Medicine 1966;45:262-88.
41. Banker BQ: Dermatomyositis of childhood: Ultrastructural alterations of muscle and intramuscular vessels. J Neuropathol Exp Neurol 1975;34:46-15.
42. Gayraud M, Tome F, Herson S, Chevallay M, Fardeau M, Godeau P: Aspects histo-pathologiques des polymyosites et dermatomyosites. Corrélation avec le mode évolutif clinique. Ann Méd Interne (Paris) 1989;140:445-8.
43. Kerr JFR, Wyllie AH, Currie AR: Apoptosis, a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
44. Trapani JA, Smyth MJ: Killing by cytotoxic T cells and natural killer cells: Multiple granule serine proteases as initiators of DNA fragmentation. Immunol Cel Biol 1993;71:201-8.
45. Young JDE: Killing of target cells by lymphocytes: A mechanistic view. Physiol Rev 1989;69:250-314.
46. Cherin P, Crevon MC, Hauw JJ, Galanaud P, Herson S, Emilie D: Mechanisms of lysis by cytotoxic cells in inflammatory myopathies: Studies of perforin and serine esterase gene expression by in situ hybridization and expression of protein TIA-1 by immunochemistry (abstr). Arthritis Rheum 1993;(suppl)36:S84.
47. Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies: V: Identification and quantification of T8+ cytoloxic and T8+ suppressor cells. Ann Neurol 1988;23:493-9.
48. Mueller C, Gershenfeld HK, Lobe CG, Okada CY, Bleackley RC, Weissman IL: A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases. but do not express the MEL-14-defined lymph node homing receptor. J Exp Med 1988;167:1124-36.
49. Muller C, Kagi D, Aebischer T, et al: Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol 1989;19:1253-9.
50. Young LH, Joag SV, Zheng LM, Lee CP, Lee YS, Young JDE: Perforin-mediated myocardial damage in acute myocarditis. Lancet 1990;1:1019-21.
51. Young LHY, Klavinskis LS, Oldstone MBA, Ding-E Young J: In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection. J Exp Med 1989;169:2159-71.
52. Nagler-Anderson C, Lichtenheld M, Eisen HN, Podack ER: Perforin mRNA in primary peritoneal exudale cytotoxic T lymphocytes. J Immunol 1989;43:3440-3.
53. Wood GS, Mueller C, Warnke RA, Weissman IL: In situ localization of HuHF serine protease mRNA and cytotoxic cell associated antigens in human dermatoses. Am J Pathol 1988;133:218-25.
54. Devergne O, Peuchmaur M, Crevon MC, Trapani JA, Maillot MC, Galanaud P, Emilie D: Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infected patients. AIDS 1991;5:1071-9.
55. Nakanishi H, Monden T, Morimoto H, Kobayashi T, Shimano T, Mori T: Perforin expression in lymphocytes infiltrated to human colorectal cancer. Br J Cancer 1991;64:239-42.
56. Müller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S: Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:477-84.
57. Orimo S, Koga R, Goto K, et al: Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994;4:219-26.